Danish Researchers Proceed with Controversial Hepatitis B Vaccine Trial in Guinea-Bissau

A research trial that involves withholding the recommended dose of the hepatitis B vaccine from thousands of newborns in Guinea-Bissau has received approval to proceed. This study is a key component of the vaccine agenda for Robert F. Kennedy Jr., who currently serves as the Secretary of the U.S. Department of Health and Human Services and is a prominent vaccine skeptic.

The trial, led by Danish researchers, has drawn criticism for its methodology, which includes withholding the vaccine from a portion of the newborn population. Public health advocates and medical professionals have raised concerns about the ethical implications and potential impact on public health efforts to prevent hepatitis B infections, a disease that can lead to serious liver conditions.